Unihealth Hospitals Ltd
Unihealth Hospitals Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
UniHealth plans a significant multi-pronged expansion over 5-7 years, targeting greenfield projects, acquisitions, and operational management outsourcing. UniHealth plans multi-pronged expansion via greenfield projects, acquisitions, and O&M, targeting 1,000 beds by FY 27-28.
From Unihealth Hospitals Ltd's Q2 FY26 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- UniHealth plans a significant multi-pronged expansion over 5-7 years, targeting greenfield projects, acquisitions, and operational management outsourcing.
- FY 27-28 target: achieve 1,000 beds.
- Revenue contribution from Uganda is currently 90%, expected to drop to 50-60% by end of FY 27-28, with India contributing 40-50%; Tanzania to add revenue in coming years.
- Navi Mumbai and Nashik hospitals (India) expected to contribute ~INR125 crore revenue next financial year.
- Navi Mumbai (52 beds) aims for 60-70% occupancy in FY 27; Nashik (200 beds) to reach ~50% occupancy by Q2 FY 28.
- Average revenue per occupied bed in India expected to scale from INR27,000-28,000 to INR55,000-60,000 over 3-5 years.
2 more points from Unihealth Hospitals Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Unihealth Hospitals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Navi Mumbai capex completed using IPO proceeds from 2023.
- Nashik financial closure achieved via equity and bank debt (INR 22 crores from Bank of India).
- 20-bedded secondary care center in Tanzania achieved financial closure with internal equity approvals.
- Planned 100-bedded tertiary care hospital in Tanzania under final discussion; funding needed.
- Pune has a multi-pronged expansion plan including greenfield projects, operational acquisitions, or O&M models.
- Target to achieve 1,000 operational beds across India and Africa by FY 2027-28.
- Future projects like Pune and the 100-bed Tanzania facility will require a mix of internal accruals, bank debt, and possibly capital leasing.
2 more points from Unihealth Hospitals Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Unihealth Hospitals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Currently, UniHealth Hospitals is handling about 1,300 beds on a consolidated basis in consultancy projects, which has been stable over the last 12+ months.
- They have completed some smaller consultancy projects recently and added a couple of new ones.
- There are ongoing discussions for consultancy projects involving an additional 600-650 beds in total.
- These discussions are in initial stages, pending financial closure by the investors before formal agreements.
- UniHealth is a shortlisted consultant for these projects, but no formal contracts have yet been signed.
- Project cycles from initial consultancy to completion typically take 2 to 5 years.
2 more points from Unihealth Hospitals Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Continue your research
What Unihealth Hosp's management said in earlier quarters
Others in Healthcare Services this season
- Maitreya Medica. (Q2 FY26)
23.92 crore (Page 26). Key investor presentation takeaways from Maitreya Medica.'s Q2 FY26 investor presentation — and how it ranks against sector peers.
- Metropolis Healt (Q2 FY26)
Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…
- 3B Blackbio (Q2 FY26)
Q2 FY 2025-26 sales: ₹3042.83 Lakh (including COVID sales ₹10.23 Lakh), up from ₹2457.55 Lakh in Q2 FY 2024-25. Key concall takeaways from 3B Blackbio DX Ltd's…
- Indegene Ltd (Q2 FY26)
Indegene is making strategic investments ahead of the curve to capitalize on market opportunities over the next 6 to 8 quarters, which will cause near-term…
Arthneeti Pro · Annual
Unihealth Hospitals Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Unihealth Hospitals Ltd Q2 FY26 results?
UniHealth plans a significant multi-pronged expansion over 5-7 years, targeting greenfield projects, acquisitions, and operational management outsourcing. UniHealth plans multi-pronged expansion via greenfield projects, acquisitions, and O&M, targeting 1,000 beds by FY 27-28.
What is Unihealth Hospitals Ltd share price analysis?
Unihealth Hospitals Ltd currently shows a neutral. The stock trades at a P/E of 41.9 with a market cap of ₹1,075 Cr. Investors should review the full earnings analysis for detailed insights.
Is Unihealth Hospitals Ltd planning capital expenditure?
Navi Mumbai capex completed using IPO proceeds from 2023.
Keep Unihealth Hospitals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.